Search
Search Results
##search.searchResults.foundPlural##
-
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3767PDF: 1273HTML: 3912Untitled: 246Untitled: 281 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3824PDF: 1625HTML: 826Figures . Eliassian: 238 -
Common parasite with uncommon associations
1539PDF: 685HTML: 1852 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1206PDF: 510HTML: 402 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1775PDF: 959HTML: 252 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1151PDF: 464HTML: 275 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2338PDF: 1208HTML: 281 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2936PDF: 980HTML: 7484 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2239PDF: 1644HTML: 386 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3126PDF: 900HTML: 7289Kost Fig1: 204Kost Fig 2: 193Kost Fig3: 196Kost Fig 4: 208Kost Fig5: 207Kost fig 6: 193 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2888PDF: 1046HTML: 248Suppl. Files: 526 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2421PDF: 1885HTML: 158 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1344PDF: 1119PDF: 908HTML: 189 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2675PDF: 1654HTML: 2440Table1: 206 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1010PDF: 1240HTML: 118 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1228PDF: 857HTML: 3412 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1444PDF: 575HTML: 229 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2269PDF: 996HTML: 1978 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2639PDF: 822HTML: 5357 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2644PDF: 896HTML: 17579Fig1 Caligaris: 195Fig.2 Caliga: 239 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1042PDF: 382HTML: 236 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1869PDF: 934HTML: 1018Referring article: 765 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2032PDF: 1216HTML: 790 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1718PDF: 498HTML: 4033 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1734PDF: 1290HTML: 488







